RESULTS FOR : 'Regulatory'
Showing 1 to 4 of 4 results |    
Keyword Search
Results Category/Section
Phenotypic Screening - Advancing the science from discovery to regulatory science

Phenotypic screening is transforming drug discovery as advances are made in development of human-based physiologically-relevant in vitro systems.

Therapeutic Drug Repurposing, Repositioning and Rescue Part III: Market exclusivity using Intellectual Property and regulatory pathways

There is a growing consensus that Drug Repurposing, Repositioning and Rescue (DRPx) can impact the prescription drug industry for all concerned stakeholders. In part this is due to the fact that the pharmaceutical industry now accrues ~25% of its annual revenues from DRPx products.

How drug regulatory authorities are adapting to new technologies

The past few years have seen the emergence of a number of new technologies. Some of these advances will have a significant effect on the nature of medicines and the way in which they are developed. This article discusses some of the significant changes in the regulatory oversight of drug development and licensing.

Personalised Medicine Market and Regulatory Landscape

Over the past several years, there has been continuing interest in the deployment of personalised medicine via the development of companion diagnostics/therapeutics.